Epitheloid hemangioendothelioma in patient with liver transplantation.

Abstract

Malignant hepatic epithelioid hemangioendothelioma (HEH) is a rare malignant tumor of vascular origin with unknown aetiology and a variable natural course. At the time of diagnosis, most patients present with multifocal tumours lesions that involve both liver lobes. From the therapeutic aspect, liver resection (LRx), liver transplantation (LTx), chemotherapy, radiotherapy, and/or immunotherapy have been used in the treatment of patients with HEH. However, because of the rarity of this tumor and its unpredictable natural history, it is impossible to assess the effectiveness of these respective therapies. In this report, our objective was to present clinical aspects, diagnostic options, therapeutic modalities, and the clinical outcome of single patient with LTx because of this rare tumor.

• Authors: Tajana Filipec Kanizaj, Vesna Colić Cvrlje, Anna Mrzljak, Ika Kardum-Skelin, Dunja Sustercić, Dinko Segro, Denis Gustin, Branislav Kocman
• Journal: Collegium antropologicum (Coll Antropol) Vol. 34 Issue 1 Pg. 177-80 (Mar 2010) ISSN: 0350-6134 [Print] Croatia
• PMID: 20432748 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antigens, CD34
• May-Grunwald Giemsa
• Platelet Endothelial Cell Adhesion Molecule-1
• Methylene Blue
• Eosine Yellowish-(YS)

Topics

• Antigens, CD34 (metabolism)
• Biopsy, Fine-Needle
• Eosine Yellowish-(YS)
• Female
• Hemangioendothelioma, Epithelioid (metabolism, pathology, surgery)
• Humans
• Liver Neoplasms (metabolism, pathology, surgery)
• Liver Transplantation
• Methylene Blue
• Middle Aged
• Platelet Endothelial Cell Adhesion Molecule-1 (metabolism)